Vor Biopharma stockVOR
Vor Biopharma trades at $18.66, 28.2% below its 52-week high (Sep 8, 2026). The price is below its 50-day but above its 200-day average: a pullback within an uptrend. +42.7% year to date, −10.8% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Mar 25, 2027.
Ratings, candles, signals and the screener for VOR — after you log in
Open the terminalFrequently asked questions about Vor Biopharma
What is the Vor Biopharma stock price?
At the close on Nov 5, 2026: $18.66 (−7.26% on the day). 52-week high: $26.00 on Sep 8, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Vor Biopharma report earnings?
The next quarterly report is on Mar 25, 2027. Last quarter, earnings per share changed +99% year over year, revenue 0%.
Does Vor Biopharma pay dividends?
No, Vor Biopharma does not pay dividends.
Where does Vor Biopharma trade and how to buy it?
Ticker VOR, exchange Nasdaq, listed since 2021. You can buy it through a broker with access to US exchanges.
Should I buy Vor Biopharma now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for VOR are in the terminal after you log in.